Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus. - Wikidata - wikimedia - TriplyDB

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

http://www.wikidata.org/entity/Q44709441

about

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.Current antiviral therapy for chronic hepatitis B.Application of hepatitis B virus replication mouse model Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B.Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus.Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.Antiviral efficacy of adefovir dipivoxil versus lamivudine in patients with chronic hepatitis B sequentially treated with lamivudine and adefovir due to lamivudine resistance.Acyclic nucleoside phosphonates: a key class of antiviral drugs.Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.Too much of a good thing? When to stop catch-up vaccination Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis Response-guided treatment of cirrhotic chronic hepatitis B patients: multicenter prospective study YMDD variants of HBV DNA polymerase gene: rapid detection and clinicopathological analysis with long-term lamivudine therapy after liver transplantation.Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients.Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B: A meta-analysis Virological response to adefovir monotherapy and the risk of adefovir resistance Emerging drugs for hepatitis B.Recent advances in the management of chronic hepatitis B.Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients Lamivudine for chronic hepatitis B.Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.Current therapies for chronic hepatitis B virus infection.Adefovir dipivoxil in chronic hepatitis B infection.Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis.Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.Management of chronic hepatitis B virus infection: a new era of disease control.Personal view: the management of chronic hepatitis B infection.Review article: hepatitis B and liver transplantation.

P2860

Q24683341-F2539465-FBB0-4CB3-A858-38FCEA97A151 Q25256648-E81605F2-7889-4552-8F52-7E64A9130149 Q26859121-A2B37556-C58D-47ED-BD8B-03F7A8E92119 Q30440211-810F9838-84A5-463C-B94B-547ECD6FC2C8 Q33233245-A2AF9CCD-368B-4675-9111-ADF7993A7F68 Q33242705-133E7982-14B3-403A-8894-4FD27A44693B Q33492413-D0C3026C-06B5-4D4A-BD7C-B8219A704DE4 Q33631693-FFDCCD05-2108-4F90-9C9F-2B634045D9D2 Q33812160-33644515-64A7-435B-8B72-8FD0A494D248 Q33868880-5D3999AB-3D47-4AFF-BADB-93FBE0E2969C Q33905600-A4EBB3E2-5659-4427-9F1F-D193D16F10FD Q34339608-8792CBA7-E994-4534-9C26-903AE4190D34 Q34382067-0346104B-8AE7-46A4-9FB5-64B6F33F135E Q34464655-4B2647EC-E443-45EE-8758-C56FE0B29CEE Q34584406-176BF38C-EE4F-4181-961F-D66A94371CAC Q34585496-61228315-DCB6-4758-9C84-1AA369D85EF8 Q34594403-624022BC-7F3B-4088-8F06-95ACA0EA8FD6 Q34604733-C03A8195-BAAD-408B-A99C-7A9A9D20EAB5 Q34615975-8494B180-49D2-4DE0-803A-63223A944787 Q34974141-48EF7C04-F625-402B-8A9E-6A2C6FE26678 Q35011213-D6556701-9A9F-4DDE-843D-EB48A2729F82 Q35152367-1606927E-F3D0-4DB0-9F8C-63C463BBE983 Q35180009-484E870B-4E40-47AB-8DA8-24BF97742F2C Q35185125-5CE90738-C74B-4D6C-BA71-8864CB59674F Q35359369-E0ECD7A5-7739-449C-AD43-8079DEB4C0DC Q35582461-B1D6A279-8EF8-44F8-9E4C-54D64524DDCE Q35632910-40668176-987E-4024-A215-7DB471015859 Q35637506-B55312FB-397F-498A-8478-952A89B39C67 Q35785174-C9A1BE88-F6B2-4A1F-B61D-77C8C24F9B0D Q35833258-8CF1E326-CA7E-4D99-9407-1994483D27A4 Q35917357-258F5B7B-1A27-4908-8B1A-3754CDAC3A05 Q35917447-76348AAC-45FC-4840-91CF-ED837107E436 Q35917541-2C9FAA64-2642-45FF-B669-877951A72B7E Q35925551-2537FFF3-9467-4EA9-877D-564EAFE7071C Q35988546-47FE64D3-5819-42FA-B828-D1C6F37FA4A0 Q36135493-2349B7AA-DC1D-43EB-9845-B03A3019787E Q36304057-6DCAC9EB-2FAF-43EA-A7F2-378CF9648CE2 Q36393856-412B19F3-22B8-4FA0-B8AB-087617227964 Q36435893-A1513487-9DD4-42BE-8FAB-0A23E47CBCDA Q36447557-184FCE7E-8884-40C7-AC24-5A24A406DEA3

P2860

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

http://www.wikidata.org/entity/Q44709441

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@en

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@nl

type

label

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@en

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@nl

prefLabel

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@en

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@nl

P1433

Q44709441-AADC1E75-D38B-47C2-A0B7-8EFFF6248F0D

P1476

Q44709441-7DB7176F-E7AA-481F-A06E-C64041D8A412

P2093

Q44709441-0ADBD623-CC2A-4299-9159-B981FA0A97D1

Q44709441-4B6E8D8D-BE58-456A-BAB7-28B9BB053529

Q44709441-710D0E25-F5DD-4334-8780-2A1C47C897A9

Q44709441-71B9E939-D910-4053-A015-B1ADBAD97D02

Q44709441-847C1BA4-A3A5-4E3D-9A56-F1E3B50B5F0E

Q44709441-AEF3CF25-EA4F-47A6-A761-20B900DFBFD0

Q44709441-B7959BD9-AD99-46E6-ABE0-8B53A29E5FBB

Q44709441-CF38DB5D-B0AF-4C53-9D15-169AA6C3BBB3

Q44709441-D1EA83EC-3169-4468-B2FA-6FF28D0D4607

Q44709441-DE5715DC-8C06-42CC-A0A2-789734E800AF

P304

Q44709441-68C0B02E-04AD-41DB-8927-CAD464791579

P31

Q44709441-7CBC0931-517A-4D52-82CA-CA85983C5B5A

P356

Q44709441-F4A5213B-5810-4812-A65C-6F6DCD82A048

P407

Q44709441-5EF52CED-C11A-4330-94D1-AA6A9708A333

P433

Q44709441-C701C8CF-3292-4CB9-A896-8D14C0C701FD

P478

Q44709441-00A2222D-9E87-440E-9DC0-B342C9789556

P577

Q44709441-869A4C03-27AC-4AD7-AB66-8073DECB5AD4

P698

Q44709441-4306DD47-3AE5-4151-8C04-C371B33C4F57

P356

J.GASTRO.2003.10.050

P1433

Gastroenterology

P1476

Adefovir dipivoxil added to on ...... YMDD mutant hepatitis B virus.

@en

P2093

Alison Moorat

http://www.w3.org/2001/XMLSchema#string

Bernard Willems

http://www.w3.org/2001/XMLSchema#string

Carol L Brosgart

http://www.w3.org/2001/XMLSchema#string

David Mutimer

http://www.w3.org/2001/XMLSchema#string

Eric Bourne

http://www.w3.org/2001/XMLSchema#string

Eugene Schiff

http://www.w3.org/2001/XMLSchema#string

Hie-Won Hann

http://www.w3.org/2001/XMLSchema#string

Mary Woessner

http://www.w3.org/2001/XMLSchema#string

Nancy Leung

http://www.w3.org/2001/XMLSchema#string

Robert Perrillo

http://www.w3.org/2001/XMLSchema#string

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2003.10.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14699490

http://www.w3.org/2001/XMLSchema#string